Gail M Farfel Insider Trading
Get free email notifications about insider trading for Gail M Farfel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gail M Farfel. Gail M Farfel is a Director in DURECT CORP ($DRRX) and a Chief Clinical Dev & Reg Offic in MARINUS PHARMACEUTICALS INC ($MRNS) and a EVP/Chief Development Officer in ZOGENIX, INC. ($ZGNX) and a Director in AVROBIO, Inc. ($AVRO).
Address: C/O MARINUS PHARMACEUTICALS, INC. 142 TEMPLE ST., SUITE 205 NEW HAVEN 06510 CT
Companies in which Gail M Farfel is an Insider
AVROBIO, Inc.
Trading Symbol: AVROIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Gail M Farfel: Director
Holdings: 0 shares
Latest Transaction: Oct 21 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DURECT CORP
Trading Symbol: DRRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gail M Farfel: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 18 2020
$DRRX Market Capitalization: $139.97M
$DRRX Previous Close: $1.03
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MARINUS PHARMACEUTICALS INC
Trading Symbol: MRNSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gail M Farfel: Chief Clinical Dev & Reg Offic
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 23 2015
$MRNS Market Capitalization: $23.45M
$MRNS Previous Close: $1.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZOGENIX, INC.
Trading Symbol: ZGNXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gail M Farfel: EVP/Chief Development Officer
Holdings: 13,109 shares
Current Value: $111,427
Latest Transaction: Mar 30 2021
$ZGNX Market Capitalization: $228.07M
$ZGNX Previous Close: $8.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gail M Farfel
Sentiment: All, AVRO, DRRX, MRNS, ZGNX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2021 | ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Developme ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Mar 30 2021 | ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Developme ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Mar 30 2021 | ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Developme ... | Option Exercise | A | 18.76 | 30,000 | 562,800 | 30,000 | |
Mar 30 2021 | ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Developme ... | Option Exercise | A | 18.76 | 30,000 | 562,800 | 30,000 | |
Mar 17 2021 | ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Developme ... | Option Exercise | M | 0.00 | 1,500 | 0 | 4,500 | |
Mar 17 2021 | ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Developme ... | Option Exercise | M | 0.00 | 2,031 | 0 | 4,062 | |
Mar 17 2021 | ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Developme ... | Option Exercise | M | 0.00 | 1,625 | 0 | 1,625 |